Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer

Israel Medical Association Journal

Volumn 8, Issue 5, 2006, Pages 342-346

  Sperber, Fani ^a,b   Weinstein, Yuliana ^a,b   Sarid, David ^a,b   Yosef, Rami Ben ^a,b   Shalmon, Annat ^a,b   Yaal Hahoshen, Neora ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Clinical and imaging assessment; Locally advanced breast cancer; Neoadjuvant chemotherapy

Indexed keywords

EPIRUBICIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EPIRUBICIN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES;

EID: 33744486868     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fischer B, Redmond C, Poisson R, et al. Eight-year results of a randomized trial comparing total mastectomy and lumpectomy with or without radiation in the treatment of breast cancer N Engl J Med 1989;32:822-8.
2. Veronesi U, Cascinelli N, Luigi M, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
3. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;42:27-41.
4. Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
5. Calais G, Berger C, Descamps P, et al. Conservative treatment feasibility with induction chemotherapy, surgery and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 1994;74:1283-8.
6. Segel MC, Paulus DD, Hotobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169:49-54.
7. Fornage BD, Toubas O, Morel M. Clinical, mammographic and sonographic determination of preoperative cancer size. Cancer 1987;60:765-71.
8. Hieken TJ, Harrison J, Herreros J, Velasco JM. Correlating sonography, mammography and pathology in the assessment of breast cancer size. Am J Surg 2001;182:351-4.
9. Gawne-Cain ML, Smith E, Darby M, Given-Wilson R. The use of ultrasound for monitoring breast tumor response in neoadjuvant therapy. Clin Radiol 1995;50:681-6.
10. Loprinzi C, Thome S. Understanding the utility of adjuvant systemic therapy for primary breast cancer. J Clin Oncol 2001;19:972-9.
11. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 1995;180:297-306
12. Haagensen CD. Diseases of the Breast. Philadelphia: WB Saunders, 1986:502.
13. Harris JR. Diseases of the Breast. 2nd edn. Philadelphia: WB Saunders, 2000:33.
14. Herrada J, Iyer RB, Atkison EN, Sneige N, Buzdar AU, Hortobagyi GN. Relative value of physical examination, mammography and breast sonography in evaluating the size of primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997;9:1565-9.
15. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
16. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;98:468-73.
17. Schnall MD, Blume J, Bluemke D, et al., for the International Breast MRI Consortium. MRI detection of multi-focal breast carcinoma: report from the International Breast MRI Consortium. J Clin Oncol 2004;22(Suppl):14S.
18. Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-8.
19. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2003;81:1275-82.
20. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. Am J Roentgenol 2002;179:1193-9.
21. Smith IC, Ogston KN, Whitford P, et al. Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 1998;228:220-7.
22. Hubner KF, Smith GT, Thie JA, et al. The potential of F-18-FDG PET in breast cancer: detection of primary lesions, axillary lymph node metastases, or distant metastases. Clin Pos Imag 2000;3:197-205.
23. Adler LP, Crowe JP, Al-Kaisi NK, et al. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-d-glucose PET. Radiology 1993;187:743-24.
24. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [18f] fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000;18:1689-1695.
25. Schott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005;92:231-8.